Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RYAM Stock Summary
Top 10 Correlated ETFs
RYAM
In the News

RYAM President and CEO to Present at the Stifel 2023 Cross Sector Insight Conference
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Rayonier Advanced Materials Inc. (NYSE:RYAM) announced today that De Lyle Bloomquist, President and Chief Executive Officer will be presenting at the Stifel 2023 Cross Sector Insight Conference on Wednesday, June 7, 2023, and hosting meetings with investors. Marcus Moeltner, the Company's Chief Financial Officer and Senior Vice President Finance is unable to attend as previously announced. About RYAM RYAM is a global leader of cellulose-based technologies, i.

RYAM CFO, SVP Finance to Present at the Stifel 2023 Cross Sector Insight Conference
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Rayonier Advanced Materials Inc. (NYSE:RYAM) announced today Marcus J. Moeltner, its Chief Financial Officer, Senior Vice President Finance, will be presenting at the Stifel 2023 Cross Sector Insight Conference on Wednesday, June 7, 2023, and hosting meetings with investors. About RYAM RYAM is a global leader of cellulose-based technologies, including high purity cellulose specialties, a natural polymer commonly found in filters, food, pharmaceuticals and ot.

2 Cheap Stocks And 1 Cheap Sector The Insiders Are Buying
Regional banks are trading at deep values, and insiders are buying. Rayonier gets an upgrade, and insiders buy.

Is Rayonier Advanced Materials (RYAM) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Rayonier Advanced Materials (RYAM) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Rayonier Advanced Materials (RYAM) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Rayonier Advanced Materials (RYAM) Loses -18.28% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Rayonier Advanced Materials (RYAM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Rayonier Advanced Materials: Improving EBITDA, Free Cash Flow, And Debt Ratios
RYAM's net debt-to-EBITDA has been decreasing since 2019 and reached 4.16x at the end of 2022, which is anticipated to sit at 3.5x in 1Q 2023. In 2023, RYAM's adjusted free cash flow should be way better than in 2022 and 2021.

Are Investors Undervaluing Rayonier Advanced Materials (RYAM) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

RYAM President & CEO to present at Gabelli Funds 14th Annual Specialty Chemicals Symposium
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Rayonier Advanced Materials Inc. (NYSE:RYAM) announced today De Lyle W. Bloomquist, President and CEO, will be presenting at the Gabelli Funds 14th Annual Specialty Chemicals Symposium on Thursday, March 16, 2023, at 1:00 PM ET. About RYAM RYAM is a global leader of cellulose-based technologies, including high purity cellulose specialties, a natural polymer commonly found in filters, food, pharmaceuticals and other industrial applications.
RYAM Financial details
RYAM Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 42.18 | 32.56 | 27.5 | 22.12 | 26.87 | |
Net income per share | 2.54 | -2.16 | 0.02 | -0.75 | -0.39 | |
Operating cash flow per share | 4.88 | 0.77 | 1.96 | 3.65 | 1.08 | |
Free cash flow per share | 2.27 | -1.12 | 0.74 | 2.15 | -1.08 | |
Cash per share | 2.15 | 1.17 | 1.49 | 4.58 | 2.38 | |
Book value per share | 13.97 | 12.53 | 10.99 | 12.79 | 12.97 | |
Tangible book value per share | 12.93 | 11.7 | 10.38 | 12.3 | 12.59 | |
Share holders equity per share | 13.97 | 12.53 | 10.99 | 12.79 | 12.97 | |
Interest debt per share | 24.67 | 21.04 | 18.3 | 15.74 | 14.38 | |
Market cap | 538.92M | 209.33M | 412.33M | 363.41M | 613.54M | |
Enterprise value | 1.62B | 1.23B | 1.4B | 1.04B | 1.31B | |
P/E ratio | 4.2 | -1.77 | 412.33 | -7.57 | -24.54 | |
Price to sales ratio | 0.25 | 0.12 | 0.24 | 0.26 | 0.36 | |
POCF ratio | 2.18 | 4.98 | 3.33 | 1.57 | 8.89 | |
PFCF ratio | 4.7 | -3.43 | 8.77 | 2.65 | -8.89 | |
P/B Ratio | 0.76 | 0.31 | 0.59 | 0.45 | 0.74 | |
PTB ratio | 0.76 | 0.31 | 0.59 | 0.45 | 0.74 | |
EV to sales | 0.76 | 0.69 | 0.81 | 0.74 | 0.77 | |
Enterprise value over EBITDA | 4.25 | 17.53 | 7.88 | 8.12 | 7.82 | |
EV to operating cash flow | 6.55 | 29.22 | 11.31 | 4.48 | 19.05 | |
EV to free cash flow | 14.1 | -20.12 | 29.84 | 7.59 | -19.05 | |
Earnings yield | 0.24 | -0.56 | 0 | -0.13 | -0.04 | |
Free cash flow yield | 0.21 | -0.29 | 0.11 | 0.38 | -0.11 | |
Debt to equity | 2.79 | 2.63 | 2.64 | 2 | 1.83 | |
Debt to assets | 0.74 | 0.72 | 0.73 | 0.67 | 0.65 | |
Net debt to EBITDA | 2.83 | 14.54 | 5.56 | 5.28 | 4.17 | |
Current ratio | 1.93 | 2.01 | 2.16 | 2.19 | 1.95 | |
Interest coverage | 3.27 | -1.28 | 0.37 | -0.15 | 0.39 | |
Income quality | 1.92 | -0.36 | 0 | 3.52 | -2.56 | |
Dividend Yield | 0.05 | 0.09 | 0 | 0 | 0 | |
Payout ratio | 0.22 | -0.16 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.05 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.54 | -2.45 | -0.62 | -0.41 | -2 | |
Capex to revenue | -0.06 | -0.06 | -0.04 | -0.07 | -0.08 | |
Capex to depreciation | -0.89 | -0.67 | -0.51 | -0.68 | -1.02 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0.01 | |
Graham number | 28.24 | 24.7 | 1.98 | 14.73 | 10.68 | |
ROIC | 0.06 | -0.03 | 0 | 0 | 0.01 | |
Return on tangible assets | 0.05 | -0.05 | 0 | -0.02 | -0.01 | |
Graham Net | -30.35 | -26.99 | -22.86 | -16.84 | -16.82 | |
Working capital | 345.67M | 288M | 341M | 421M | 336M | |
Tangible asset value | 654.41M | 637.55M | 656.56M | 782.57M | 804.58M | |
Net current asset value | -1.26B | -1.22B | -1.2B | -855M | -829M | |
Invested capital | 1.68 | 1.58 | 1.56 | 1.14 | 1.03 | |
Average receivables | 201.84M | 202.02M | 209.76M | 220.44M | 207.87M | |
Average payables | 175.33M | 172.96M | 154.95M | 163.09M | 166.71M | |
Average inventory | 311.73M | 286.28M | 242.33M | 232.09M | 248.01M | |
Days sales outstanding | 38.03 | 37.36 | 49.93 | 52.63 | 45.22 | |
Days payables outstanding | 39.3 | 32.49 | 35.73 | 46.4 | 37.54 | |
Days of inventory on hand | 65.52 | 53.27 | 53.23 | 63.17 | 60.76 | |
Receivables turnover | 9.6 | 9.77 | 7.31 | 6.94 | 8.07 | |
Payables turnover | 9.29 | 11.24 | 10.22 | 7.87 | 9.72 | |
Inventory turnover | 5.57 | 6.85 | 6.86 | 5.78 | 6.01 | |
ROE | 0.18 | -0.17 | 0 | -0.06 | -0.03 | |
Capex per share | -2.61 | -1.89 | -1.22 | -1.49 | -2.16 |
Quarterly Fundamentals Overview
Last date of statement is 2023-04-01 for Q1
Metric | History | 2022-03-26 | 2022-06-25 | 2022-09-24 | 2022-12-31 | 2023-04-01 |
---|---|---|---|---|---|---|
Revenue per share | 5.52 | 6.25 | 7.28 | 7.81 | 7.24 | |
Net income per share | -0.38 | -0.37 | 0.3 | 0.06 | 0.04 | |
Operating cash flow per share | -0.37 | -0.2 | 0.68 | 0.97 | 0.79 | |
Free cash flow per share | -1.08 | -0.85 | 0.25 | 0.59 | 0.47 | |
Cash per share | 3.56 | 2.31 | 2.06 | 2.38 | 2.62 | |
Book value per share | 12.34 | 11.91 | 12.19 | 12.96 | 12.88 | |
Tangible book value per share | 12.34 | 11.47 | -396.98 | 12.57 | 12.53 | |
Share holders equity per share | 12.34 | 11.91 | 12.19 | 12.96 | 12.88 | |
Interest debt per share | 14.77 | 14.43 | 13.9 | 13.6 | 13.35 | |
Market cap | 429.18M | 169.33M | 237.33M | 614.24M | 404.44M | |
Enterprise value | 1.18B | 927.04M | 978.33M | 1.32B | 1.08B | |
P/E ratio | -4.47 | -1.77 | 3.12 | 38.39 | 37.87 | |
Price to sales ratio | 1.22 | 0.42 | 0.51 | 1.23 | 0.87 | |
POCF ratio | -18.25 | -13.27 | 5.48 | 9.91 | 7.93 | |
PFCF ratio | -6.25 | -3.12 | 14.87 | 16.16 | 13.48 | |
P/B Ratio | 0.55 | 0.22 | 0.3 | 0.74 | 0.49 | |
PTB ratio | 0.55 | 0.22 | 0.3 | 0.74 | 0.49 | |
EV to sales | 3.34 | 2.32 | 2.1 | 2.63 | 2.32 | |
Enterprise value over EBITDA | 93.24 | 29.02 | 32.61 | 22.68 | 21.63 | |
EV to operating cash flow | -49.99 | -72.64 | 22.6 | 21.21 | 21.2 | |
EV to free cash flow | -17.12 | -17.08 | 61.31 | 34.61 | 36.05 | |
Earnings yield | -0.06 | -0.14 | 0.08 | 0.01 | 0.01 | |
Free cash flow yield | -0.16 | -0.32 | 0.07 | 0.06 | 0.07 | |
Debt to equity | 2.1 | 2.13 | 1.99 | 1.83 | 1.78 | |
Debt to assets | 0.68 | 0.68 | 0.67 | 0.65 | 0.64 | |
Net debt to EBITDA | 59.21 | 23.72 | 24.7 | 12.09 | 13.54 | |
Current ratio | 1.97 | 1.85 | 2.02 | 1.95 | 2.06 | |
Interest coverage | -0.88 | -0.11 | -0.3 | 0.94 | 1.13 | |
Income quality | 0.95 | 0.52 | 2.36 | 15.5 | 25.5 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | 1.92 | 3.25 | -0.63 | -0.39 | -0.41 | |
Capex to revenue | -0.13 | -0.1 | -0.06 | -0.05 | -0.04 | |
Capex to depreciation | -1.65 | -1.23 | -0.78 | -0.62 | -0.6 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0 | 0 | 0 | |
Graham number | 10.22 | 10.01 | 9.03 | 4.27 | 3.46 | |
ROIC | -0.01 | 0 | 0 | 0.02 | -0.08 | |
Return on tangible assets | -0.01 | -0.01 | 0.01 | 0 | 0 | |
Graham Net | -17.98 | -18.46 | -17.59 | -16.8 | -16.13 | |
Working capital | 366.57M | 323.1M | 347M | 336M | 341M | |
Tangible asset value | 757.51M | 732.91M | 753.83M | 804.58M | 808.33M | |
Net current asset value | -907.37M | -919.84M | -868M | -829M | -817M | |
Invested capital | 1.18 | 1.19 | 1.12 | 1.03 | 1.02 | |
Average receivables | 111.18M | 226.41M | 224.43M | 215.57M | 207M | |
Average payables | 96.7M | 188.64M | 169.01M | 159.05M | 160.76M | |
Average inventory | 111.66M | 232.99M | 256.1M | 267.43M | 251.35M | |
Days sales outstanding | 56.9 | 51.95 | 42.18 | 38.29 | 38.79 | |
Days payables outstanding | 50.34 | 44.42 | 33.11 | 32.36 | 32.98 | |
Days of inventory on hand | 58.12 | 58.63 | 57.89 | 52.37 | 49.68 | |
Receivables turnover | 1.58 | 1.73 | 2.13 | 2.35 | 2.32 | |
Payables turnover | 1.79 | 2.03 | 2.72 | 2.78 | 2.73 | |
Inventory turnover | 1.55 | 1.54 | 1.55 | 1.72 | 1.81 | |
ROE | -0.03 | -0.03 | 0.02 | 0 | 0 | |
Capex per share | -0.71 | -0.65 | -0.43 | -0.38 | -0.33 |
RYAM Frequently Asked Questions
What is Rayonier Advanced Materials Inc. stock symbol ?
Rayonier Advanced Materials Inc. is a US stock , located in Jacksonville of Fl and trading under the symbol RYAM
Is Rayonier Advanced Materials Inc. buy or a sell ?
2 stock analysts have 2 predictions with a medium analyst target price of $6.5. The lowest prediction is $5 and the highest is $8
What is RYAM stock prediction ?
What is Rayonier Advanced Materials Inc. stock quote today ?
Rayonier Advanced Materials Inc. stock price is $4.4 today.
Is Rayonier Advanced Materials Inc. stock public?
Yes, Rayonier Advanced Materials Inc. is a publicly traded company.